FDA Submits Collection of Information for OMB Review Under Paperwork Reduction Act

Summary

The Food and Drug Administration (FDA) has submitted a proposed collection of information to the Office of Management and Budget (OMB) for review and clearance, as required by the Paperwork Reduction Act of 1995, in relation to the Index of Legally Marketed Unapproved New Animal Drugs for Minor Species.